Antimicrobial Susceptibility Testing of Antimicrobial Peptides Requires New and Standardized Testing Structures.

Area of Science:

• Microbiology
• Biochemistry
• Pharmacology

Background:

• Antimicrobial peptides (AMPs) are crucial in innate immunity and represent a promising therapeutic class.
• Current research faces challenges due to a lack of optimized and standardized testing systems for AMPs.
• Expert consensus is vital for advancing AMP development and application.

Purpose of the Study:

• To address the need for optimized and standardized test systems for novel antimicrobial peptides (AMPs).
• To collate expert opinions on AMP susceptibility testing, mode of action, and clinical relevance.
• To provide data-driven suggestions for improving AMP research methodologies.

Main Methods:

• Discussions at the International Meeting on Antimicrobial Peptides (IMAP) 2017 and Gordon Research Conference (GRC) on Antimicrobial Peptides 2019.
• A survey circulated to international experts in the field of antimicrobial peptides.
• Analysis of survey responses regarding test method optimization, standardization, and clinical relevance.

Main Results:

• Experts recognize the importance of susceptibility testing for understanding AMP mechanisms.
• A significant need for optimization and standardization of AMP test methods was identified.
• The clinical relevance of standardized AMP testing is a key consideration for future research.

Conclusions:

• Standardized testing protocols are essential for reliable evaluation of antimicrobial peptides.
• Future research should focus on developing and validating optimized methods for AMP assessment.
• Improved testing will enhance the understanding and clinical application of AMPs.